First-in-Human Trial of VBC106 in Participants With Advanced Solid Tumors

NCT07686068 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Participants With Advanced Solid Tumor Malignancies

Interventions

DRUG: VBC106

Sponsor

VelaVigo Bio Inc